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Inflammatory myofibroblastic tumor (IMT) is a rare lesion of unclear pathogenesis that shows a wide, highly variable
spectrum of clinical behavior. We describe the case of a 17-year-old boy with a large IMT that infiltrated the
bladder, ileocecal junction, peritoneum and pelvic retroperitoneal space. The tumor was associated with extensive
toughening and thickening of the bladder, and, although it showed a tendency for invasive growth, it affected
mainly the bladder and adjacent tissue. To the best of our knowledge, this case report is the first to describe an
IMT involving the entire bladder and several adjacent pelviabdominal organs. The bladder wall was tough and
could hardly be cut by scalpel. Levels of inflammatory response markers such as C-reactive protein fell after surgery.
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Inflammatory myofibroblastic tumor (IMT) is a rare lesion
of unclear pathogenesis that exhibits highly variable and
unpredictable clinical behavior [1]. Developing a clear
understanding of IMT pathophysiology is challenging,
in part because of variability in terminology. For instance,
IMTs are now classified as neoplastic lesions, but they
were termed inflammatory pseudotumors 20 years ago [2].
IMTs in adults usually occur in the lungs [3]. Abdom-
inal and retroperitoneal IMTs, by comparison, are usually
larger and more aggressive and show high local recurrence
rates [4]. In rare cases, IMTs have been found in the blad-
der, and some authors have suggested that these tumors
are sufficiently different from other IMTs that they should
be considered a special category [5].
Herein we present the case of a 17-year-old boy with a
large IMT that encroached on the bladder, ileocecal junc-
tion, peritoneum and pelvic retroperitoneal space. To
the best of our knowledge, this case report is the first to* Correspondence: 854375067@qq.com
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reproduction in any medium, provided the ordescribe an IMT involving the entire bladder and sev-
eral adjacent pelviabdominal organs.Case presentation
A 17-year-old boy was referred to our hospital because
of urinary frequency, urinary urgency and weight loss
over the preceding 2 months. He had no history of urinary
tract infection or abdominal trauma, nor had he ever
undergone surgery. A physical examination showed him
to be of thin build and pale. A tender, fixed mass in the
suprapubic area was found by palpation. Laboratory test
results showed elevated levels of numerous disease indi-
cators, including the inflammatory marker C-reactive
protein (CRP) and globins (Table 1).
The patient was negative for the following tests and
markers: colonoscopy, thyroid hormones, hepatitis B and
C infection, IgM, IgA, antistreptolysin O prostate-specific
antigen and α-fetoprotein (AFP). The patient was also
negative for the following tumor makers: carcinoembryonic
antigen (CEA), CA 125, CA 15–3, CA 19–9, CA 242 and
CA 72–4.
Contrast-enhanced computed tomography (CT) revealed
a 5 cm × 6 cm × 7–cm, irregular, neoformative mass
involving the ileocecal junction, bladder and adjacent
peritoneum. The bladder wall showed uneven thickeninghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Laboratory test resultsa
Test At admission 50 days after surgery Normal reference range
Blood
C-reactive protein 89.05 mg/L 10.16 mg/L 0 to 10 mg/L
hs-CRP 6.4 mg/L 3 mg/L 0 to 3 mg/L
IgG 27.81 g/L 19.9 g/L 8 to 16 g/L
Platelets 386 × 109/L 315 × 109/L 100 to 300 × 109/L
Total protein 96.7 g/L ND 60 to 80 g/L
Globulin 54.8 g/L ND 25 to 35 g/L
Albumin/globulin ratio 0.76 ND 1 to 2.5
White blood cell count 9.18 × 109/L 6 × 109/L 3.97 to 9.15 × 109/L
Percentage of neutrophils 74.6% 62.3% 45 to 77%
Percentage of lymphocytes 19.0% 27.8% 20 to 40%
Hemoglobin 119 g/L 98.0 g/L 131 to 172 g/L
Mean corpuscular volume (MCV) 77.90 fl 81.00 fl 86 to 100 fl
Mean corpuscular hemoglobin (MCH) 25.80 pg 25.20 pg 26 to 31 pg
Alexin C4 0.41 g/L 0.32 g/L 0.2 to 0.4 g/L
Alexin C3 1.47 g/L 1.52 g/L 0.9 to 1.5 g/L
Erythrocyte sedimentation rate ND 55 mm/h 0 to 15 mm/h
Urine
Urinary microalbumin ≥150 mg/L ND <20 mg/L
ahs-CRP high-sensitivity C-reactive protein, IgG immunoglobulin G, ND not done.
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Some ascites were present.
Exploratory laparotomy was performed. A large, poorly
defined, noncapsulated, fixed mass was found involving
the inferior ventrimeson peritoneum, ileocecal junction,
mesentery, bladder and perivesical fat tissue. The bladder
wall was tough and difficult to cut, reminiscent of coconut
endocarp or thick eggshell. It showed extensive, uneven
thickening (Figure 2). Its thickness was at least 0.9 cm
and significantly more in some areas. Extensive pelvic
retroperitoneal fibrosis was observed It extended into
the seminal vesicles and Denonvilliers’ fascia and encased
the inferior ureter, vas deferens.Figure 1 Enhanced computed tomography scan of the pelvis. (A) Enh
thickening of the bladder wall and heterogeneous enhancement performa
neoformative mass involving the adjacent peritoneum and ileocecal junctioSurgery was performed to excise the tumor. The
peritoneum and ileocecal junction were partially resected,
the bladder was also partially resected and ileocystoplasty
was performed.
Intraoperative microscopic analysis suggested a spindle
cell lesion with mucoid degeneration. Subsequent path-
ology analysis showed bland, spindle-shaped myofibroblasts
loosely arranged in a myxoid stroma with plasma cells
and inflammatory cells (Figure 3). Resected bladder
tissue specimens were positive for smooth muscle actin
and CD68 and negative for desmin and anaplastic lymph-
oma kinase (ALK). They showed low expression of Ki-67.
Mesenteric lymph nodes (three of three) showed reactiveanced computed tomography (CT) scan of the pelvis showing uneven
nce. (B) Enhanced CT revealing infiltration by a large, irregular,
n.
Figure 2 Resected specimen. Macrobiopsy (8 cm × 6 cm × 4 cm)
obtained during exploratory laparotomy showing the bladder with a
white, fibrotic-like, tough wall and a polished mucosa.
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and colon was made.
Laboratory tests showed substantial reductions in nu-
merous markers of disease and inflammation by 50 days
after surgery (Table 1). Follow-up at 6 months showed
no evidence of tumor recurrence, and ultrasound and
cystoscopy tests gave negative results.Figure 3 Lesion characteristics under microscope. (A), and (B) High-po
proliferating myofibroblasts and fibrous tissue of full thickness. Large numb
of the bladder, leading to microabscesses (C). (D) Detrusor muscles of theDiscussion
IMTs range from benign to locally invasive [1], and they
have been proposed to be caused by chronic infection,
an immune or autoimmune condition, trauma, surgery
or other malignancies [5]. The primary tumor is usually
found as an isolated nodular lesion in the lungs, abdomen
or retroperitoneum in adults [3,4] and intraabdominally in
the mesentery and omentum in children [6]. They rarely
occur in the genitourinary tract. IMTs in the lower uro-
genital tract are probably a special type of IMT. They are
often associated with surgical trauma and have been
proposed to be an exuberant reparative reaction [7]. We
were unable to determine a likely cause of the IMT in
our patient. IMTs in the bladder can be associated with
von Recklinghausen disease [8], but the characteristic
orbital pseudotumor and thyroid lesions were absent in
our patient.
Although some IMTs are very aggressive, spreading
locally and recurring after successful excision [9], the
IMT lesions in our patient appeared to be inflammatory
rather than malignant. This assessment is based on sev-
eral lines of anatomical and biochemical evidence. First,
the detrusor muscles of the bladder were intact, whereas
they are usually damaged when a bladder tumor is
aggressively malignant (Figure 3). Second, the patient
presented with elevated levels of several inflammatory
markers: serum CRP, high-sensivity CRP, white cells
and immunoglobulin G. These levels declined with disease
remission, as observed previously [10]. Third, the pa-
tient was negative for AFP and CEA- and CA-type
tumor markers.wer magnification photomicrographs of the bladder showing
ers of lymphocytes, plasmocytes and neutrophils infiltrated the plasma
bladder were not collapsed.
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cell proliferation in a myxoid to collagenous stroma with
a prominent inflammatory infiltrate comprised primar-
ily of plasma cells and lymphocytes [11]. The IMTs may
be mistaken for spindle-cell sarcoma, sarcomatoid car-
cinoma, rhabdomyosarcoma or leiomyosarcoma [6].
It is important to avoid mistaking sarcomatoid carcin-
oma for IMT. The former, with its prominent myxoid
and sclerosing stroma, may be mistaken for IMT [12].
However, IMTs lack severe cytologic atypia, atypical mi-
totic figures and extensive necrosis. In addition, IMT
often features a myxoid background, inflammatory
infiltrate and prominent, slitlike vessels [12]. Most of
all, the detrusor muscles of the bladder in IMTs were
not collapsed, as our current case shows. The presence of
necrosis at the tumor–detrusor muscle interface may help
to distinguished sarcoma from IMT [11].
The IMT in our patient was negative for ALK-1, which
has been reported in up to 87.5% of IMTs, whereas
ALK-1 was found to be negative in sarcomatoid carcin-
oma, leiomyosarcoma and neurofibroma [13], but such
reactivity does not appear to correlate with the prognosis
of IMTs. The IMT in our patient involved several organs,
which is uncommon. So many tissues were involved in
our patient, in fact, that we could not identify the primary
site. We are confident that the tumor did not originate in
the intestine because the intestinal tissue adjacent to the
bowel appeared normal, and it did not show adhesions to
the bowel. Lesions of the urachus can infiltrate into the
rectus abdominis muscle, colon, bladder and terminal
ileum [14], but our patient had a normal umbilicus. Thus,
although the lesion in our patient showed a tendency for
invasive growth, it affected mainly adjacent fixed tissue.
IMTs in the bladder have been found at numerous
sites [15], but they are found most often at the dome [6].
In our patient, however, the trigone of the bladder was
not involved, except for secondary invasion from the
posterior wall. The bladder wall was tough and, except
for part of the trigone, could hardly be cut by scalpel.
The mucosa was thickening with waxy luster. Interest-
ingly, although the bladder trigone was thickened in our
patient, it was soft and had a normal appearance.
IMTs in the bladder usually appear as polypoid
intraluminal or submucosal masses with or without
extension into the perivesical fat [16]. Our patient, in
contrast, showed a tough, diffuse lesion featuring un-
even thickening of the bladder. To the best of our
knowledge, this case report is the first to describe such
an IMT.
The radiological characteristics of the IMT of our
patient, like those of most IMTs, were between those
of malignant tumors and those of inflamed tissue. As
in the case of our patient, CT typically shows a soli-
tary, uneven, peripheral, sharply circumscribed mass,as well as thickening of the bladder wall. Enhanced CT
showed heterogeneous performance.
IMTs have been successfully treated with steroids, non-
steroidal inflammatory drugs, radiotherapy and chemo-
therapy [17]. Nevertheless, the treatment of choice for
IMT remains complete surgical excision. A review of
35 pediatric patients with IMT (median age 7 yr) who
were treated by surgical excision found no evidence of
recurrence or metastasis after a median follow-up of
1.5 years among 29 of the patients [6].
In addition to IMT, our patient presented with ex-
tensive pelvic retroperitoneal fibrosis that extended
into the seminal vesicles and Denonvilliers’ fascia and
encased the inferior ureter. The inferior ureters were
soft and appeared normal following the removal of their
fibrotic shell. Partial cystectomy was carried out through
intraoperative freezing, and nearly the entire bladder
was removed, leaving only tissue normal in appearance.
In our patient, the prostate was not taken away, and the
neurovascular bundle was not spared due to the fibrotic
lesion of bladder. Although the patient showed no evi-
dence of IMT recurrence and no erectile dysfunction,
close follow-up is necessary.
Conclusion
The IMT of the 17-year-old boy in this case involved the
entire bladder and showed a tendency for invasive growth,
although it affected mainly adjacent fixed tissue. The
clinical, radiographic and pathological characteristics of
the tumor were between those of benign and malignant
lesions. The patient presented with elevated levels of
inflammatory response markers, which fell after surgery.
The patient also presented with extensive pelvic retroperi-
toneal fibrosis involving the entire bladder and several
adjacent pelviabdominal organs. The bladder wall was
tough and could hardly be cut by scalpel. Close follow-
up is necessary to check for tumor recurrence or metastasis.
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